ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Cambodia to mix vaccines as booster shots to fight COVID

Lockdown in provinces bordering Thailand aims to prevent spread of delta variant

A garment factory worker receives a China's Sinovac coronavirus disease (COVID-19) vaccine at an industrial park in Phnom Penh.   © Reuters

PHNOM PENH (Reuters) -- Cambodia will begin offering a booster shot against Covid-19, switching between the AstraZeneca and Chinese COVID-19 vaccines in an effort to fight the spread of the coronavirus in the Southeast Asian country.

Prime Minister Hun Sen, launching the vaccination campaign for 12-17 years old, said on Sunday that the third dose will be offered to between 500,000 to one million frontline workers as a priority.

"People who have already been vaccinated with Sinopharm and Sinovac should be given AstraZeneca as the third booster dose," Hun Sen said in a speech which was broadcast on social media. "For Cambodians who have been vaccinated with AstraZeneca, Sinovac should be given as the third dose," he added.

Hun Sen also said the country will purchase more AstraZeneca vaccines through Covax for the booster shots and the recent U.S funded Johnson & Johnson vaccines will be used to vaccinate indigenous peoples in northeastern Cambodia.

Cambodia has launched a lockdown in eight provinces bordering Thailand this week in a bid to prevent the spread of the Delta variant of the coronavirus in the Southeast Asian country.

The World Health Organization (WHO) said this week that the Delta variant has been detected amongst migrants returning from Thailand through land borders and is now in the local community.

"We are racing against new variants. We must act today, and we must act fast to have no regrets tomorrow," said Li Ailan, WHO Representative to Cambodia, in a statement on Saturday.

Cambodia managed to largely contain the virus for most of last year, but an outbreak first detected in late February has driven up total cases to 77,919, with 1,420 deaths.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more